Andrés F. Cardona

Researcher Next ID · RN-024944

Researcher · Medicine

Paris, Colombia

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

Lung Cancer Diagnosis and Treatment

Cancer Immunotherapy and Biomarkers

Cancer Genomics and Diagnostics

Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2310532
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
The Lancet Oncology · 2023 · https://doi.org/10.1016/s1470-2045(23)00469-2
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)32409-7
Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)
Journal of Thoracic Oncology · 2015 · https://doi.org/10.1097/jto.0000000000000481

No projects listed.